These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 24213148)
1. Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. de Masson A; Beylot-Barry M; Bouaziz JD; Peffault de Latour R; Aubin F; Garciaz S; d'Incan M; Dereure O; Dalle S; Dompmartin A; Suarez F; Battistella M; Vignon-Pennamen MD; Rivet J; Adamski H; Brice P; François S; Lissandre S; Turlure P; Wierzbicka-Hainaut E; Brissot E; Dulery R; Servais S; Ravinet A; Tabrizi R; Ingen-Housz-Oro S; Joly P; Socié G; Bagot M; Haematologica; 2014 Mar; 99(3):527-34. PubMed ID: 24213148 [TBL] [Abstract][Full Text] [Related]
2. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. Duvic M; Donato M; Dabaja B; Richmond H; Singh L; Wei W; Acholonu S; Khouri I; Champlin R; Hosing C J Clin Oncol; 2010 May; 28(14):2365-72. PubMed ID: 20351328 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study. de Masson A; Beylot-Barry M; Ram-Wolff C; Mear JB; Dalle S; d'Incan M; Ingen-Housz-Oro S; Orvain C; Abraham J; Dereure O; Charbonnier A; Cornillon J; Longvert C; Barete S; Boulinguez S; Wierzbicka-Hainaut E; Aubin F; Rubio MT; Bernard M; Schmidt-Tanguy A; Houot R; Pham-Ledard A; Michonneau D; Brice P; Labussière-Wallet H; Bouaziz JD; Grange F; Moins-Teisserenc H; Jondeau K; Michel L; Mourah S; Battistella M; Daguindau E; Loschi M; Picard A; Franck N; Maillard N; Huynh A; Nguyen S; Marçais A; Chaby G; Ceballos P; Le Corre Y; Maury S; Bay JO; Adamski H; Bachy E; Forcade E; Socié G; Bagot M; Chevret S; Peffault de Latour R; ; ; Lancet; 2023 Jun; 401(10392):1941-1950. PubMed ID: 37105210 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma. Cudillo L; Cerretti R; Picardi A; Mariotti B; De Angelis G; Cantonetti M; Postorino M; Ceresoli E; De Santis G; Nasso D; Pisani F; Scala E; Di Piazza F; Lanti A; Ann Hematol; 2018 Jun; 97(6):1041-1048. PubMed ID: 29442161 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Duarte RF; Canals C; Onida F; Gabriel IH; Arranz R; Arcese W; Ferrant A; Kobbe G; Narni F; Deliliers GL; Olavarría E; Schmitz N; Sureda A J Clin Oncol; 2010 Oct; 28(29):4492-9. PubMed ID: 20697072 [TBL] [Abstract][Full Text] [Related]
6. Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas. Isufi I; Seropian S; Gowda L; Wilson LD; Roberts K; Girardi M; Perreault S; Foss F Leuk Lymphoma; 2020 Dec; 61(12):2955-2961. PubMed ID: 32643494 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Mamez AC; Dupont A; Blaise D; Chevallier P; Forcade E; Ceballos P; Mohty M; Suarez F; Beguin Y; Peffault De Latour R; Rubio MT; Tournilhac O; Nguyen S J Hematol Oncol; 2020 May; 13(1):56. PubMed ID: 32429979 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC). Vigouroux S; Michallet M; Porcher R; Attal M; Ades L; Bernard M; Blaise D; Tabrizi R; Garban F; Cassuto JP; Chevalier P; Facon T; Ifrah N; Renaud M; Tilly H; Vernant JP; Kuentz M; Bourhis JH; Bordigoni P; Deconinck E; Lioure B; Socié G; Milpied N; Haematologica; 2007 May; 92(5):627-34. PubMed ID: 17488686 [TBL] [Abstract][Full Text] [Related]
18. Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas. Delioukina M; Zain J; Palmer JM; Tsai N; Thomas S; Forman S Bone Marrow Transplant; 2012 Jan; 47(1):65-72. PubMed ID: 21358679 [TBL] [Abstract][Full Text] [Related]
19. Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia. Hsu J; Artz A; Mayer SA; Guarner D; Bishop MR; Reich-Slotky R; Smith SM; Greenberg J; Kline J; Ferrante R; Phillips AA; Gergis U; Liu H; Stock W; Cushing M; Shore TB; van Besien K Biol Blood Marrow Transplant; 2018 Feb; 24(2):359-365. PubMed ID: 29128555 [TBL] [Abstract][Full Text] [Related]
20. The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease. Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M Clin Transplant; 2019 Jun; 33(6):e13537. PubMed ID: 30873642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]